PMA · Approved
ApprovedASSURE Wearable Cardioverter Defibrillator (WCD) System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Kestra Medical Technologies, Inc. · MVK Wearable Automated External Defibrillator
Approved on Jul 27, 2021 through premarket approval, which rests on the device’s own clinical evidence after a 348-day review.
- Decided
- Jul 27, 2021
- Review
- 348 days
- Class
- Class III
- Product code
- MVK
- Recalls
- None
PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.
P200037 has 19 supplements since 2021: changes to the approved device, its labelling or its manufacturing, each approved separately.
PMA supplements approved per year
View FIG. 1 as a table
| Year | Supplements approved |
|---|---|
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 4 |
Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in MVK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
Does it have a predicate?
PMA decisions do not claim a predicate device.
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
How does its category compare?
All MVK devicesMVK Wearable Automated External Defibrillator: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.
FDA decisions per year · MVK
15in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · MVK
Too few MVK 510(k)s in any year since 2007 to give a median.
Recalls per year · MVK
1in 2017
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · MVK
12,137in 2025
MAUDE reports naming product code MVK, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 2 | 446 |
| 2008 | 2 | — | 1 | 690 |
| 2009 | 6 | — | 0 | 946 |
| 2010 | 4 | — | 1 | 1,363 |
| 2011 | 8 | — | 0 | 1,975 |
| 2012 | 10 | — | 0 | 3,375 |
| 2013 | 6 | — | 0 | 3,805 |
| 2014 | 7 | — | 0 | 5,086 |
| 2015 | 15 | — | 0 | 8,415 |
| 2016 | 15 | — | 0 | 9,463 |
| 2017 | 12 | — | 1 | 10,853 |
| 2018 | 8 | — | 0 | 9,941 |
| 2019 | 22 | — | 0 | 9,894 |
| 2020 | 14 | — | 0 | 11,904 |
| 2021 | 14 | — | 0 | 12,466 |
| 2022 | 6 | — | 0 | 12,667 |
| 2023 | 17 | — | 0 | 12,988 |
| 2024 | 21 | — | 0 | 12,585 |
| 2025 | 15 | — | 0 | 12,137 |
| 2026 | 13 | — | 0 | — |
https://510kreport.com/device/P200037 · printed Nov 3, 2026
Cite this page
510(k) Report. “P200037: ASSURE Wearable Cardioverter Defibrillator (WCD) System.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/P200037
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Page last updated Nov 3, 2026